Search - tctmd.com

Displaying 301 - 320 of 609

Sort: Relevancy | Date

News Conference News SCAI 2019

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

Yael L. Maxwell

May 21, 2019

Taking Ticagrelor? Frank, Proactive Patient Conversations are Needed to Help With Adherence

News Daily News

Taking Ticagrelor? Frank, Proactive Conversations are Needed to Help With Adherence

Yael L. Maxwell

May 17, 2019

News Daily News

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

Caitlin E. Cox

May 14, 2019

News Daily News

Bariatric Surgery Linked to Survival Advantage After MI and CVA

Michael O'Riordan

May 13, 2019

News Daily News

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

Michael O'Riordan

April 30, 2019

News Daily News

Patients Retain Little From Cath Lab Informed-Consent Conversations

Michael O'Riordan

April 26, 2019

News Daily News

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Michael O'Riordan

April 12, 2019

News Daily News

Does PCI Public Reporting Affect Angiography for Out-of-Hospital Cardiac Arrest?

Michael O'Riordan

April 11, 2019

News Daily News

Baseline Anemia Ups Physician-Guided DAPT Discontinuation Rates After PCI

Yael L. Maxwell

April 10, 2019

News Conference News ACC 2019

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

Yael L. Maxwell

March 27, 2019

News Conference News ACC 2019

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

Michael O'Riordan

March 18, 2019

News Conference News ACC 2019

AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI

Caitlin E. Cox

March 17, 2019

News Daily News

Atherosclerosis Features Differ Among Male Athletes From Different Sports

Todd Neale

February 18, 2019

News Daily News

Genetic Risk Factor Discovered for Spontaneous Coronary Artery Dissection

Todd Neale

January 18, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2018

Caitlin E. Cox

January 01, 2019

News Daily News

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

Caitlin E. Cox

December 11, 2018

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

News Conference News AHA 2018

Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia

Michael O'Riordan

November 11, 2018

News Daily News

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Michael O'Riordan

November 06, 2018

News Daily News

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

Yael L. Maxwell

November 05, 2018

Advertisement

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

Taking Ticagrelor? Frank, Proactive Conversations are Needed to Help With Adherence

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

Bariatric Surgery Linked to Survival Advantage After MI and CVA

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

Patients Retain Little From Cath Lab Informed-Consent Conversations

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Does PCI Public Reporting Affect Angiography for Out-of-Hospital Cardiac Arrest?

Baseline Anemia Ups Physician-Guided DAPT Discontinuation Rates After PCI

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI

Atherosclerosis Features Differ Among Male Athletes From Different Sports

Genetic Risk Factor Discovered for Spontaneous Coronary Artery Dissection

TCTMD’s Top 10 Most Popular Stories for December 2018

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content